From the Investor Seat to the Founder’s Booth: Victoria’s SAAS NORTH Evolution.
For years, miRoncol Health’s CEO, Victoria Xu, has attended SAAS NORTH as an investor, walking away with game-changing insights. The “Masked Investor” talk last year? It was a playbook that directly guided miRoncol Health’s successful fundraising this year.
Now, Victoria is returning, but with a new title and a much sharper focus!
Our CEO is incredibly excited to be here as a founder this time. She is not just looking to learn from investors; Victoria wants to connect with peers and, most importantly, hear directly from the participants who are the ultimate users of our AI powered blood test for early cancer warning among healthy individuals.
Come say hello, share your perspective, and help us continue to build a solution that truly matters to empower consumer health.
From the miRoncol archive: This historical update may contain promotional language or research findings that do not describe the current service. Retrospective research results do not establish prospective screening performance, and references to scientific prizes do not imply evaluation or endorsement of miRoncol or miCheckup. Do not rely on this archive for healthcare decisions; use the current product information and discuss screening decisions with a healthcare professional.